Italy
Italy

Time filter

Source Type

The March of Dimes and Saint Luke's worked with mom photographers – some whose children had previously been in the NICU – to document the sweet bonding sessions, gifting the keepsake photos to families. "Mother's Day – especially a mom's very first with her new baby – can be hard for many families with children in the NICU," says March of Dimes president Stacey D. Stewart. "Our NICU Family Support program works with Saint Luke's Hospital and more than 100 other hospitals around the United States to offer the support families need to have the best possible experience when their baby is in the NICU. From providing the chance to build a loving bond by using the sense of touch with kangaroo care, to commemorating milestones like Mother's Day, the March of Dimes is proud to partner with hospitals like St. Luke's to give every baby and every family a healthy, loving start." To view and share these intimate Mother's Day photos and video, click here. All photos should be dual credited to March of Dimes and the photographer whose name is watermarked in each photo.  Video is to be credited to Saint Luke's Hospital of Kansas City. The March of Dimes NICU Family Support Program® at Saint Luke's Hospital supports moms who are on bed rest and at the bedside with premature or critically ill children in the NICU. The program also educates NICU staff about the best ways to support babies, families and each other. Babies born premature (before 37 weeks of pregnancy), even born just a few weeks too soon, can face serious health challenges and are at risk for lifelong disabilities including breathing problems, vision loss, cerebral palsy, and intellectual delays. In the United States, about 380,000 babies are born too soon each year – that's 1 in 10. The premature birth rate in our country is higher than that in most other high-resource nations. The March of Dimes is supporting cutting-edge research at a nationwide network of five Prematurity Research Centers, where about 200 of the brightest minds are collaborating to create major breakthroughs in prematurity. By working together, March of Dimes-funded scientists and researchers are finding answers to the unknown causes of premature birth. Saint Luke's will also host a kangaroo-a-thon May 9-14, 2017 encouraging time spent with mom and baby enjoying skin-to-skin contact and supported by Saint Luke's NICU staff. Kangaroo care has documented benefits for both parent and baby. Benefits for baby include: It can also be beneficial for mom: Saint Luke's hospitals deliver more than 6,000 babies every year.  Saint Luke's offers the most advanced expertise and services to expectant mothers and their babies. Saint Luke's NICUs offer advanced care for premature babies and infants requiring critical care. We utilize a team of experts, including neonatologists, lactation consultants, nutritionists and nurses to care for moms on bed rest, as well as NICU and full-term babies, with care tailored to each baby's unique needs. March of Dimes is the leading nonprofit organization for pregnancy and baby health. For more than 75 years, moms and babies have benefited from March of Dimes research, education, vaccines, and breakthroughs. For the latest resources and health information, visit marchofdimes.org and nacersano.org. You can also find us on Facebook or follow us on Instagram and Twitter. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nicu-moms-and-babies-celebrate-mothers-day-with-intimate-and-beneficial-skin-to-skin-kangaroo-care-bonding-300456164.html


News Article | May 10, 2017
Site: www.labdesignnews.com

Project team: Realty Trust Group (Owner’s Program Manager); BarberMcMurry architects (Architect of Record); Shepley Bulfinch (Design Architect); ESG (Engineering Services Group) (Mechanical, Plumbing); Vreeland Engineers Inc. (Electrical); Land Development Solutions (Civil); Ross Bryan Associates Inc. (Structure); CRJA and Hedstrom Design LLC (Landscape) Description: An official opening has been held for the East Tennessee Children’s Hospital Surgery and NICU addition and renovations. Located in Knoxville, the new tower houses a 14-room surgery platform, multi-specialty outpatient clinics and a 44-room all-private neonatal intensive care unit (NICU) to meet the growing demand for pediatric health services in the region. This expansion and the accompanying renovation of vacated space in the old building fulfills the goals of Children’s Hospital’s strategic master plan, significantly upgrading its facilities and enhancing Children’s Hospital’s visibility as the region’s only comprehensive pediatric center. Symbolizing the hospital’s continued commitment to exceptional patient- and family-centered care, the roof garden with a view of the Smokey Mountains and the multi-level glass bridge featuring both family and public spaces become the central design features of the new expansion. The metal panel exterior frames the bridges and the roof garden, creating an urban signature for the new expansion, while the use of terracotta on the façade blends the addition with the existing brickwork of the older hospital buildings. The bridge spans the entryway below joining new and old, while the public spaces and roof garden animate the campus. The five-story tower, which seems to change color depending on vantage point, emphasizes the significance of natural light in this project. The entire expansion sits atop a 165-space, two-story parking garage. One of the most successful aspects of the Children’s Hospital expansion is the 44-bed NICU located on the top floor of the building. Featuring all private rooms, amenities in the new space include a family suite with kitchen facilities, resource center, and a walk-out roof garden that became a defining space for the NICU and provides a much-appreciated outdoor respite area for families and staff. The large private rooms allow for unlimited bonding time with parents and other family members, especially siblings who had previously been prohibited from visiting due to space limitations and potential health concerns.


"This is incredibly important work," added Deb Krmpotic, chief executive officer of Banner Thunderbird. "The closer to full-term that a baby can deliver, the better it is for the baby, so we're incredibly pleased to see these kind of results from our combined efforts." Dr. Gunatilake became the medical director of the MFM Program at Banner Thunderbird in July, and immediately began using methods pioneered by Dr. John Elliott, a national MFM expert in reducing pre-term delivery. "We worked collaboratively with the team at Banner Thunderbird to train them on implementing our protocols," said Dr. Gunatilake. "We couldn't be more pleased with the achievement of this milestone for mothers and babies." The chances of pre-term delivery can sometimes be hard to predict, but women with certain infections, shortened cervix, or those with a history of pre-term delivery are at greater risk. "Our team helps high-risk expectant mothers achieve the best possible outcome," said Dr. John Elliott, medical director of Valley Perinatal Services. "The fact that we can help so many mothers, who come to us scared and with little hope, speaks to the effectiveness of our program." Dr. Elliott founded Valley Perinatal Services in 2013. Dr. Gunatilake joined in May 2015 after serving as medical director of Obstetrical Services at the University of Oklahoma where he was recognized for improving obstetrical quality and safety. Dr. Gunatilake views the nine months of pregnancy as the "window of opportunity" for mothers to positively impact their babies. Banner Thunderbird Medical Center in Glendale, Arizona, specializes in heart care, surgical services, obstetrics and gynecology, emergency care, behavioral health, cancer care, rehabilitation and pediatrics including the West Valley's only pediatric intensive care unit, pediatric Emergency department and Level III neonatal intensive care unit. The hospital is part of Banner Health, a nonprofit health system with 28 hospitals in six states. For more information, please visit www.BannerHealth.com/Thunderbird. Valley Perinatal is a maternal-fetal medicine practice dedicated to reducing pre-term delivery and creating the best possible outcomes for high-risk expectant mothers. Directed by industry pioneer, Dr. John Elliott, and staffed by experienced maternal-fetal medicine specialists, nurse practitioners, and ultrasound sonographers, Valley Perinatal cares for pregnant women with complications, co-managing them alongside their obstetricians. This approach has led to higher gestational ages and decreased NICU admissions and durations for babies. Valley Perinatal provides genetic counseling, fetal therapy, in-utero procedures, obstetric ultrasound and diagnostics. Obstetricians trust Valley to coach them with their high-risk pregnancies to a successful outcome. Visit www.valleyperinatal.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valley-perinatal-services-and-banner-thunderbird-medical-center-significantly-lowering-extreme-pre-term-births-at-hospital-300456550.html


News Article | January 31, 2017
Site: www.medicalnewstoday.com

Researchers at the University of Pittsburgh and Washington University in St. Louis have provided the first details of how enteroviruses, which cause millions of infections worldwide annually, may enter the body through the intestine. The results of the study are published in the journal Proceedings of the National Academy of Sciences. Enterovirus infections are associated with diseases that can range from mild flu-like symptoms to much more severe outcomes such as inflammation in the brain or heart, acute paralysis, and even death. Enterovirus infections acquired within neonatal intensive care units (NICU) can be devastating as newborns are particularly susceptible to infection by these viruses. Enteroviruses are a class of viruses that are the second most common human infectious agents and are primarily transmitted through close person-to-person contact, touching infected surfaces, or ingesting food or water containing the virus. "Despite their major global impact, especially on the health of children, little is known about the route that these viruses take to cross the intestine, their primary point of entry. Our approach has for the first time shed some light on this process," said senior author Carolyn Coyne, Ph.D., associate professor of microbiology and molecular genetics at the Pitt School of Medicine. In the study, researchers isolated stem cells from premature human small intestines and grew them in the laboratory into enteroids, or so-called "mini-guts," which contained the different cell types and tissue structures that are normally found in the human intestine. Using the mini-gut model, they demonstrated that echovirus 11 (E11), the enterovirus most commonly associated with NICU infections, induced significant damage to the enteroids, which could facilitate passage of the virus into the bloodstream from the infected intestine. The results also provided the first evidence that different types of enteroviruses could target distinct cells within the gastrointestinal tract and might vary in their effectiveness at infecting intestinal cells. "This study not only provides important insights into enterovirus infections, but also provides an important model that could be used to test the efficacy of anti-enterovirus therapeutics in the premature intestine," said Misty Good, M.D., assistant professor of pediatrics at the Washington University School of Medicine in St. Louis and co-senior author of the study. Other authors of the study included Coyne G. Drummond, B.S., and Congrong Ma, M.Sc., of the University of Pittsburgh; and Alexa M. Bolock, B.S., and Cliff J. Luke, Ph.D., of Washington University School of Medicine in St. Louis. The study was funded by National Institutes of Health grants R01AI081759 and K08DK101608, the Burroughs Wellcome Fund, and Children's Hospital of Pittsburgh of UPMC.


DUARTE, CA--(Marketwired - Feb 17, 2017) - Prolacta Bioscience® -- the nation's leading provider of human milk-based neonatal nutritional products, announced today that it will present at the 2017 RBC Capital Markets Healthcare Conference in New York, NY. Scott Elster, Prolacta's President and Chief Executive Officer, is scheduled to present on Wednesday, February 22, 2017 at 11:20 AM EST. When used as part of an exclusive human milk diet (EHMD)1, Prolacta Bioscience's neonatal nutritional products are clinically proven to improve health outcomes2,3,4 and reduce hospital costs5,6 for critically ill, extremely premature infants in the neonatal intensive care unit (NICU) weighing between 500-1,250g at birth, as compared to cow milk-based fortifier or preterm formula. About Prolacta Bioscience Prolacta Bioscience, Inc. is a privately-held life sciences company dedicated to Advancing the Science of Human Milk®. The company pioneered the development of human milk-based neonatal nutritional products to meet the needs of critically ill, premature infants in the NICU. Prolacta leads the industry in the quality and safety of nutritional products made from breast milk and operates the first and only pharmaceutical-grade manufacturing facility for the processing of human breast milk. For more information please visit www.prolacta.com. 1 An EHMD is when 100% of the protein, fat and carbohydrates in an infant's intake are derived solely from human milk. 2 Sullivan S, et al. "An Exclusively Human Milk-Based Diet is Associated with a Lower Rate of Necrotizing Enterocolitis than a Diet of Human Milk and Bovine Milk-Based Products." The Journal of Pediatrics. April 2010. 156(4):562-567. doi: 10.1016/j.jpeds.2009.10.040. The randomized study of 207 infants weighing 500-1,250g compared the benefits of an exclusive human milk diet with a diet of both human milk-based and cow milk-based products. 3 Cristofalo EA, et al. "Randomized Trial of Exclusive Human Milk versus Preterm Formula Diets in Extremely Premature Infants." The Journal of Pediatrics. December 2013. 163(6):1592-1595. doi: 10.1016/j.jpeds.2013.07.011. The multicenter randomized controlled study examined 53 extremely premature infants weighing 500-1250g who were fed either a bovine milk-based preterm formula or an exclusive human milk diet, comparing the duration of parenteral nutrition, growth and morbidity. 4 Abrams SA, et al. "Greater Mortality and Morbidity in Extremely Preterm Infants Fed a Diet Containing Cow Milk Protein Products." Breastfeeding Medicine. June 2014. 9(6): 281-0285. doi:10.1089/bfm.2014.0024. This cohort study included 260 extremely preterm infants born weighing less than 1,250g who received a diet that ranged from 100% cow milk to 100% human milk. 5 Ganapathy V, et al. "Costs of Necrotizing Enterocolitis and Cost-Effectiveness of Exclusively Human Milk-Based Products in Feeding Extremely Premature Infants." Breastfeeding Medicine. February 2012. 7(1):29-37. doi: 10.1089/bfm.2011.0002. This cost-effectiveness analysis of 2,560 extremely premature infants less than 28 weeks gestational age in 257 hospitals nationwide, comparing the impact of an exclusive human milk diet composed of mother's milk fortified with a human milk-based fortifier versus mother's milk fortified with cow milk-based fortifier. 6 Assad M, et al. "Decreased Cost and Improved Feeding Tolerance in VLBW Infants Fed an Exclusive Human Milk Diet." Journal of Perinatology. March 2016. 36:216-220. doi: 10.1038/jp.2015.168. The study retrospectively looked at 293 preterm infants between gestational ages of 23 to 34 weeks and birth weights between 490-1,700g in the Level III NICU. The study compared the clinical and financial impacts between infants that were fed an exclusive human milk diet; cow milk-based fortifier and maternal milk; mixed combination of maternal milk, cow milk-based fortifier and cow milk-based formula; and formula between March 2009 and March 2014.


DUARTE, CA--(Marketwired - Feb 22, 2017) - Prolacta Bioscience® -- the nation's leading provider of human milk-based neonatal nutritional products, announced today that it will present at the Cowen and Company 37th Annual Health Care Conference in Boston, MA. Scott Elster, Prolacta's President and Chief Executive Officer, is scheduled to present on Tuesday, March 7, 2017 at 2:30 PM EST. When used as part of an exclusive human milk diet (EHMD)1, Prolacta Bioscience's neonatal nutritional products are clinically proven to improve health outcomes2,3,4 and reduce hospital costs5,6 for critically ill, extremely premature infants in the neonatal intensive care unit (NICU) weighing between 500-1,250g at birth, as compared to cow milk-based fortifier or preterm formula. About Prolacta Bioscience Prolacta Bioscience, Inc. is a privately-held life sciences company dedicated to Advancing the Science of Human Milk®. The company pioneered the development of human milk-based neonatal nutritional products to meet the needs of critically ill, premature infants in the NICU. Prolacta leads the industry in the quality and safety of nutritional products made from breast milk and operates the first and only pharmaceutical-grade manufacturing facility for the processing of human breast milk. For more information please visit www.prolacta.com. 1 An EHMD is when 100% of the protein, fat and carbohydrates in an infant's intake are derived solely from human milk. 2 Sullivan S, et al. "An Exclusively Human Milk-Based Diet is Associated with a Lower Rate of Necrotizing Enterocolitis than a Diet of Human Milk and Bovine Milk-Based Products." The Journal of Pediatrics. April 2010. 156(4):562-567. doi: 10.1016/j.jpeds.2009.10.040. The randomized study of 207 infants weighing 500-1,250g compared the benefits of an exclusive human milk diet with a diet of both human milk-based and cow milk-based products. 3 Cristofalo EA, et al. "Randomized Trial of Exclusive Human Milk versus Preterm Formula Diets in Extremely Premature Infants." The Journal of Pediatrics. December 2013. 163(6):1592-1595. doi: 10.1016/j.jpeds.2013.07.011. The multicenter randomized controlled study examined 53 extremely premature infants weighing 500-1250g who were fed either a bovine milk-based preterm formula or an exclusive human milk diet, comparing the duration of parenteral nutrition, growth and morbidity. 4 Abrams SA, et al. "Greater Mortality and Morbidity in Extremely Preterm Infants Fed a Diet Containing Cow Milk Protein Products." Breastfeeding Medicine. June 2014. 9(6): 281-0285. doi:10.1089/bfm.2014.0024. This cohort study included 260 extremely preterm infants born weighing less than 1,250g who received a diet that ranged from 100% cow milk to 100% human milk. 5 Ganapathy V, et al. "Costs of Necrotizing Enterocolitis and Cost-Effectiveness of Exclusively Human Milk-Based Products in Feeding Extremely Premature Infants." Breastfeeding Medicine. February 2012. 7(1):29-37. doi: 10.1089/bfm.2011.0002. This cost-effectiveness analysis of 2,560 extremely premature infants less than 28 weeks gestational age in 257 hospitals nationwide, comparing the impact of an exclusive human milk diet composed of mother's milk fortified with a human milk-based fortifier versus mother's milk fortified with cow milk-based fortifier. 6 Assad M, et al. "Decreased Cost and Improved Feeding Tolerance in VLBW Infants Fed an Exclusive Human Milk Diet." Journal of Perinatology. March 2016. 36:216-220. doi: 10.1038/jp.2015.168. The study retrospectively looked at 293 preterm infants between gestational ages of 23 to 34 weeks and birth weights between 490-1,700g in the Level III NICU. The study compared the clinical and financial impacts between infants that were fed an exclusive human milk diet; cow milk-based fortifier and maternal milk; mixed combination of maternal milk, cow milk-based fortifier and cow milk-based formula; and formula between March 2009 and March 2014.


DUARTE, CA--(Marketwired - Feb 16, 2017) - Prolacta Bioscience®, the pioneer in human milk-based neonatal nutritional products, announced today that the first patient has been enrolled in a clinical study to evaluate the effect of a specially fortified exclusive human milk diet (EHMD)1 to improve growth in infants who have undergone surgery for a serious heart defect known as single ventricle cardiac physiology. Prolacta developed a first-of-its-kind, human milk-based fortifier to address the post-surgical nutrition needs of this fragile infant population. Single ventricle cardiac physiology occurs in five out of 100,000 live births,2 and results in a range of clinical problems resulting from the heart having only one adequate ventricle or pumping chamber.2 The condition is usually fatal unless treated by a series of surgeries.3 Babies with single ventricle cardiac physiology often have difficulty breathing, feeding and growing.3,4 "These medically frail newborns are at high risk for growth failure, due to increased caloric demands due to their heart and pulmonary conditions. This presents unique nutritional challenges," said Principal Investigator Cynthia Blanco, M.D., University of Texas Health Science Center. "We believe a densely fortified human milk diet may be a real benefit to these infants with an ultimate goal of optimizing their nutritional status prior to their second surgery." "While not preemies, these babies have a similar need for rich nutrition delivered in small volumes," said Scott Elster, CEO of Prolacta. "This study is the first to explore the benefits of human milk-based fortifiers in a population of fragile infants other than preemies. The medical centers will be using a new formulation that we developed specifically for these babies, and we hope that it will make a difference to their health and healing." The randomized controlled study will evaluate a minimum of 84 infants, starting at age seven days or younger, who require surgery to correct a single ventricle cardiac physiology present at birth, and who were fed an EHMD prior to study enrollment. The study will measure growth rate and clinical outcomes for up to 30 days following surgery in these infants. One group will be fed an EHMD that includes a new formulation of Prolacta's highest caloric density exclusive human milk-based fortifier, while the other group will receive a standard diet that includes some cow milk-based nutrition. The hypothesis is that infants fed the EHMD will have short-term benefits, including improved growth, reduced episodes of feeding intolerance, sepsis and necrotizing enterocolitis (damaged intestinal tissue), reduced stay in the hospital and potentially improved long-term neurodevelopmental outcomes. The study is titled, "A Randomized Controlled Trial to Evaluate Growth Velocity and Clinical Outcomes of Infants with Single Ventricle Physiology Fed an Exclusive Human Milk Diet with Early Nutritional Fortification Following Surgical Repair." It is expected to take place at 12 centers: University of Texas Health Science Center at San Antonio (lead center), San Antonio, Texas; University of Texas Southwestern Medical Center, Dallas, Texas; Texas Children's Hospital, Houston, Texas; Cook Children's Medical Center, Fort Worth, Texas; Children's Hospital of Philadelphia, Philadelphia, Pa.; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Children's Hospital of Orange County, Orange, Calif.; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill.; Columbia University Medical Center, New York, N.Y.; Emory University Hospital, Atlanta, Ga.; University of Oklahoma Health Sciences Center, Oklahoma City, Ok.; and UF Health Shands Children's Hospital, Gainesville, Fla. About Prolacta Bioscience Prolacta Bioscience, Inc. is a privately-held life sciences company dedicated to Advancing the Science of Human Milk®. The company pioneered the development of human milk-based neonatal nutritional products to meet the needs of critically ill, premature infants in the NICU. Prolacta leads the industry in the quality and safety of nutritional products made from donor breast milk and operates the first and only pharmaceutical-grade manufacturing facility for the processing of human milk. For more information, please visit www.prolacta.com. 1 An exclusive human milk diet (EHMD) is when 100 percent of the protein, fat and carbohydrates in an infant's intake are derived solely from human milk. 2 Adult Congenital Heart Association. "Single Ventricle Defects and the Fontan." Accessed Nov. 13, 2016. 3 Cadet, J.V., "Children's Hospital of Philadelphia: Treating Single Ventricle Defects." Cardiovascular Business. July 26, 2010. Accessed Nov. 13, 2016. 4 American Heart Association. "Single Ventricle Defects." Updated Oct. 21, 2015. Accessed Nov. 13, 2016.


News Article | March 1, 2017
Site: www.businesswire.com

ORLANDO, Fla.--(BUSINESS WIRE)--As a result of funds raised at the recent Diamond Resorts Invitational, Diamond Resorts International® presented a check for $570,000 to Florida Hospital for Children. The proceeds were raised during the annual event’s silent and live auctions at Mystic Dunes Resort & Golf Club in Celebration, Florida, from January 12-15, 2017. The tournament-related events have now raised more than $2.3 million for Florida Hospital for Children over the past four years. Florida Hospital for Children is one of the premier children’s hospitals in the nation, setting standards for innovation, quality and comprehensive care. The child-centric healing environment designed to keep kids comfortable is complemented by a staff of world-class doctors, specialists, nurses and healthcare professionals utilizing advanced technologies, therapies and treatments. Florida Hospital for Children’s team of over 135 highly skilled pediatric specialists delivers extraordinary care across more than 35 pediatric subspecialties, including a children's emergency department; the Level IV Comprehensive Pediatric Epilepsy Center; a world-renowned pediatric heart center; a Level III neonatal intensive care unit (NICU); and the Children’s Center for Cancer and Blood Disorders, Central Florida’s first and only pediatric bone marrow transplant program affiliated with Duke Health. Florida Hospital for Children’s flagship facility is a seven-story, 201-bed state-of-the-art hospital designed with the help of Walt Disney Imagineers, families and clinicians. (www.floridahospitalforchildren.com) “Year after year, Diamond Resorts International® exceeds our expectations and continues to provide tremendous support through proceeds raised at their live and silent auctions at the Diamond Resorts Invitational,” said Marla Silliman, Senior Executive Officer, Florida Hospital for Children. “We are honored to accept this generous donation as it will further our commitment to saving children’s lives and improving their health.” The Diamond Resorts Invitational™ was nationally televised on Golf Channel from Friday, January 13 through Sunday, January 15, and featured a groundbreaking format with 27 PGA TOUR Champions, four LPGA stars, and 48 sports and entertainment celebrities. The historic event marked the first time multiple LPGA players have competed individually against the PGA TOUR Champions in a PGA TOUR-sanctioned event. The Diamond Resorts Invitational was a week-long, full-scale, multidimensional vacation experience consisting of activities for all ages, family-friendly excursions, dinner parties and headline concerts featuring performances by Jana Kramer, Colt Ford, Jake Owen and Diamond Resorts’ newest celebrity ambassador, Cole Swindell. “The Diamond Resorts Invitational is a unique platform that allows us to leverage our ability to deliver hospitality on a large scale, while also giving back to our local community,” said Michael Flaskey, Chief Operating Officer, Diamond Resorts International®. “We have seen all the ways that our donations have made a significant impact on the lives of the children and families at Florida Hospital for Children over the years, and we are grateful for the opportunity to be a contributor to the hospital’s vital lifesaving mission.” Diamond Resorts International®, with its network of more than 370 vacation destinations located in 35 countries throughout the continental United States, Hawaii, Canada, Mexico, the Caribbean, South America, Central America, Europe, Asia, Australasia and Africa, provides guests with choice and flexibility to let them create their dream vacation, whether they are traveling an hour away or around the world. Our relaxing vacations have the power to give guests an increased sense of happiness and satisfaction in their lives, while feeling healthier and more fulfilled in their relationships, by enjoying memorable and meaningful experiences that let them Stay Vacationed.™ Diamond Resorts International® manages vacation ownership resorts and sells vacation ownership points that provide members and owners with Vacations for Life® at over 370 managed and affiliated properties and cruise itineraries.


DUBLIN, Feb. 20, 2017 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Infant Warmers and Incubators Market Analysis & Trends - Product Type (Transport Incubator, Labor and Delivery and Neonatal intensive care unit (NICU)) - Forecast to 2025" report...


News Article | February 15, 2017
Site: www.prweb.com

The National Association of Professional Women (NAPW) honors Rita Kluny as a 2016-2017 inductee into its VIP Woman of the Year Circle. She is recognized with this prestigious distinction for leadership in holistic healing. NAPW is the nation’s leading networking organization exclusively for professional women, boasting more than 850,000 members, a thriving eChapter and over 200 operating Local Chapters. “I’m pleased to welcome Rita into this exceptional group of professional women,” said NAPW President Star Jones. “Her knowledge and experience in her industry are valuable assets to her company and community.” Rita Kluny saved lives in the NICU, but there was an emotional disconnect. She explored other venues of healing and came across the American Holistic Nurses Association, becoming certified in Holistic Nursing, and Healing Touch. It is an energy-based therapy that promotes harmony and balance to accelerate one’s own healing process. She brought traditional nursing and the healing arts together to create a venue in which caretakers can better care for their babies. As a Healing Touch practitioner and instructor since 1993, Ms. Kluny started Healing Touch for Babies in 2000 and helps children and mothers all over the country. “I have a keen intuitive sense of where moms are coming from and what they need to hear to be able to move forward as they transition into motherhood,” Ms. Kluny said. To her, education is the key. With her guidance and practice, families can create the lives they want, and the quality time to go with it. Teaching those who are afraid of this unfamiliar style of medicine, love and showing the way to a new beginning makes it all worthwhile for Ms. Kluny. In the future, she hopes to create a radio show to interview experts about conscious pregnancy, birthing and parenting support. AboutNAPW NAPW’s mission is to provide an exclusive, highly advanced networking forum to successful women executives, professionals and entrepreneurs where they can aspire, connect and achieve. Through innovative resources, unique tools and progressive benefits, professional women interact, exchange ideas, advance their knowledge and empower each other.

Loading NICU collaborators
Loading NICU collaborators